State of the art and future challenges of urethra-sparing stereotactic body radiotherapy for prostate cancer: a systematic review of literature

• by Jennifer Le Guevelou, Davide Giovanni Bosetti, Francesco Castronovo, Antonio Angrisani, Renaud de Crevoisier, Thomas Zilli

• September 5, 2023

Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer

• by Wolfgang Lilleby, Amar Kishan, Hans Geinitz

• January 20, 2024

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya

• by Mustafa Barbhuiya

• March 18, 2026

• 4 min

The Benefits of Single Fraction Stereotactic Body Radiation Therapy (SBRT)

Recent research at Roswell Park Comprehensive Cancer Center led by Anurag Singh, MD, Director of Radiation Research, has shown that for patients with peripherally located lung cancer, one treatment of stereotactic body radiation therapy (SBRT) is equally effective as longer courses radiation therapy.

• March 30, 2021

• 2 min